Alpha-L-fucosidase detection reagent or kit and preparation method thereof

By using Gemini surfactant, Tween and glycerol in the α-L-fucosidase assay reagent, combined with suitable buffer solution and PEG, the problems of substrate instability and poor anti-interference performance are solved. Long-term stability and high accuracy detection of reagents are achieved.

CN119061112AActive Publication Date: 2024-12-03BIOSINO BIO TECH & SCI
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411556847.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-11-04
Publication Date
2024-12-03
Estimated Expiration
2044-11-04

AI Technical Summary

Technical Problem

The existing α-L-fucosidase assay reagent substrate is unstable in an acidic environment and has poor anti-interference performance. It is easily affected by interferers such as bilirubin, vitamin C, and hemoglobin, resulting in inaccurate detection results.

Method used

Gemini surfactant and Tween composite combined with glycerol as a protective agent, a buffer with a pH of 4.5~5.5 was used, and PEG and inorganic compounds containing metal ions were added to improve substrate stability and anti-interference ability.

Benefits of technology

It significantly improves the stability and anti-interference performance of the substrate, so that the single reagent of α-L-fucosidase can be stored at 2-8°C for 20 months, effectively removing a variety of interferers, improving detection accuracy and simplifying Operation process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
Patent Text Reader

Abstract

The invention relates to the technical field of biological agents, in particular to an alpha-L-fucosidase detection reagent or kit and a preparation method thereof. The kit comprises a substrate, a buffer solution with the pH value of 4.5-5.5, a metal ion chelating agent, an inorganic compound containing metal ions, glycerol, a Gemini type surfactant, Tween and PEG (Polyethylene Glycol). The invention provides the alpha-L-fucosidase single reagent capable of improving the substrate stability and resisting the influence of various interferents, the single reagent can be stably stored for at least 20 months at 2-8 DEG C, the interference of various serum interferents such as combined bilirubin, free bilirubin, vitamin C, chyle and hemoglobin is effectively removed, and the accuracy is relatively high. Moreover, the single reagent is convenient, simple and easy to operate, the use of instrument reagent sites is reduced, and the detection cost is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biological preparations, and in particular to an alpha-L-fucosidase detection reagent or kit and a preparation method thereof. Background Art

[0002] α-L-fucosidase (AFU) is a lysosomal acid hydrolase that is widely present in human tissues, cell lysosomes and body fluids. In addition, AFU is found in placenta, fetal tissue, brain, lung, liver, pancreas, kidney, serum, urine, saliva and tears. AFU can hydrolyze α-1,2, α-1,3, α-1,4 and α-1,6 glycosidic bonds. Its physiological function is to participate in the decomposition and metabolism of various glycolipids, glycoproteins, mucopolysaccharides and other macromolecular substances containing fucoside groups. The main clinical significance is that serum AFU is significantly increased in patients with liver cancer, so it is considered to be a new liver cancer marker for primary liver cancer (PHC). The AFU activity in the serum of patients with primary liver cancer is not only significantly higher than that of the normal control group, but also significantly higher than that of metastatic liver cancer, cirrhosis, cholangiocarcinoma, malignant mesothelioma, malignant hemangioendothelioma, congenital liver cysts and other benign liver space-occupying lesions. It is generally believed that AFU has a higher sensitivity than alpha-fetoprotein (AFP) but a lower specificity than AFP. There is no obvious correlation between AFU and AFP. The combined monitoring of the two can increase the detection rate of liver cancer, especially for AFP-negative and small cell liver cancer. AFU can also be used as an ideal indicator for postoperative monitoring and follow-up observation of PHC. Its changes are parallel to the severity of the disease and are 1-2 months earlier than clinical manifestations. Therefore, it can be used as an indicator for PHC efficacy and prognosis.

[0003] There are many methods for determining AFU in serum, such as fluorescence method, colorimetric method and rate method. The first two are difficult to automate and are rarely used. The rate method is more commonly used in combination with a fully automatic biochemical analyzer. Its detection principle is: AFU in serum catalyzes the hydrolysis of 2-chloro-p-nitrophenol-α-L-fucopyranoside (CNPF) substrate to generate 2-chloro-p-nitrophenol (CNP), causing an increase in absorbance at a wavelength of 405nm. The rate of absorbance increase is proportional to the activity of AFU in the sample.

[0004] The pH range of AFU-catalyzed substrate hydrolysis reaction is 4.1~6.2, and the optimal pH is 5.0, at which the enzyme activity is the highest. However, the substrate CNPF catalyzed by AFU has poor stability in acidic aqueous solution and is easily acidolyzed. Therefore, the reagents commonly used on the market for determining AFU are double reagents, which are cumbersome to use and occupy too many instrument reagent positions. In addition, the anti-interference performance of existing reagents is poor, and interferences such as combined bilirubin, free bilirubin, vitamin C, hemoglobin, and chyle have a greater impact on the sample detection value.

[0005] Therefore, how to provide a single reagent of α-L-fucosidase that improves substrate stability and resists the influence of multiple interferents has become a technical problem that urgently needs to be solved in this field. Summary of the invention

[0006] In order to solve the above technical problems, firstly, the present invention provides an α-L-fucosidase detection reagent (single reagent) or a kit, comprising: an α-L-fucosidase activity assay substrate, a buffer solution with a pH of 4.5 to 5.5, a metal ion chelator, an inorganic compound containing metal ions, a protective agent, a surfactant and PEG; the protective agent is glycerol, and the surfactant is a Gemini-type surfactant and Tween.

[0007] The present invention finds that the combination of a Gemini surfactant and a Tween surfactant with a protective agent glycerol can effectively slow down the acid hydrolysis of the substrate, thereby improving the substrate stability. At the same time, the present invention uses a buffer solution with a pH of 4.5 to 5.5, which can effectively increase the enzyme reaction rate, thereby ensuring the optimal pH of the enzyme reaction in the serum and the stability of the substrate. In addition, PEG is added to the reagent or kit of the present invention to achieve resistance to the influence of various interferences including chyle; the inorganic compound containing metal ions in the reagent or kit is used as an enzyme activator.

[0008] Preferably, the buffer is any one of glycine-sodium hydroxide buffer, disodium hydrogen phosphate-sodium dihydrogen phosphate buffer, dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer, disodium hydrogen phosphate-citric acid buffer, citric acid-sodium citrate buffer, citric acid-sodium hydroxide buffer, MES-sodium hydroxide buffer, acetic acid-sodium acetate buffer, and potassium hydrogen phthalate-sodium hydroxide buffer.

[0009] Preferably, the metal ion chelator is at least one of EDTA, EDTA-2Na, EDTA-4Na, and NTA.

[0010] Preferably, the inorganic compound containing metal ions is at least one of potassium chloride, sodium chloride, calcium chloride, magnesium sulfate and sodium sulfate.

[0011] Preferably, the Gemini-type surfactant is at least one of octyl polyoxyethylene hexadecyl ammonium chloride, octyl polyoxyethylene octadecyl ammonium chloride, dodecanol polyoxyethylene ether dimethyl methyl ammonium chloride, hexadecanol polyoxyethylene ether dimethyl octyl ammonium chloride, ethylene didodecyl polyoxyethylene polyoxypropylene block ammonium bromide, octadecylamine polyoxyethylene ether diquaternary ammonium salt, and hexadecanol polyoxyethylene ether dimethyl octyl ammonium chloride; the Tween is Tween-20 or Tween-80.

[0012] Preferably, the molecular weight of the PEG is 1000-20000 (e.g., PEG-1000, PEG-1500, PEG-2000, PEG-4000, PEG-6000, PEG-8000, PEG20000).

[0013] Preferably, the reagent or kit further comprises a preservative.

[0014] Preferably, the preservative is at least one of sodium azide, antibiotics (such as kanamycin, gentamicin), Proclin300, and Krovin100; and / or the concentration of the preservative is 0.5-5 g / L.

[0015] The addition of preservatives can further improve the stability of reagents or kits and prevent the growth of microorganisms.

[0016] Preferably, the concentration of the α-L-fucosidase activity assay substrate is 0.2-2 g / L, the concentration of the buffer is 20-200 mmol / L, the concentration of the metal ion chelator is 0.5-5 mmol / L, the concentration of the inorganic compound containing metal ions is 10-100 mmol / L, the concentration of the protective agent is 2-20 g / L, the concentration of the surfactant is 1-10 g / L, and the concentration of PEG is 0.5-10 g / L.

[0017] Furthermore, the present invention provides a method for preparing any of the above reagents or kits, comprising: mixing a buffer, a metal ion chelator, and an inorganic compound containing metal ions, adjusting the pH to 4.5-5.5, and then mixing with an α-L-fucosidase activity assay substrate, a protective agent, a surfactant, and PEG to prepare the reagent or kit.

[0018] In the present invention, the α-L-fucosidase activity assay substrate is 2-chloro-5-nitrobenzene-α-L-fucopyranoside (CNPF) or 2-chloro-4-nitrobenzene-α-L-fucoside (MG-CNPF).

[0019] Compared with the prior art, the present invention has the following beneficial effects: The present invention provides an α-L-fucosidase single reagent that improves substrate stability and resists the influence of multiple interfering substances. The single reagent can be stably stored at 2-8°C for at least 20 months, effectively removes the interference of multiple serum interfering substances such as bound bilirubin, free bilirubin, vitamin C, chyle and hemoglobin, and has high accuracy. Moreover, the single reagent of the present invention is convenient, simple and easy to operate, reduces the use of instrument reagent positions, and reduces the detection cost. DETAILED DESCRIPTION

[0020] In order to make the purpose, technical scheme and advantages of the present invention clearer, the technical scheme in the present invention will be described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in the field without creative work are within the scope of protection of the present invention. The preparation methods of all embodiments and comparative examples are the same as those of Example 1.

[0021] If no specific techniques or conditions are specified in the examples, all are carried out according to conventional methods or the techniques or conditions described in the literature in the field, or according to the product instructions. If no manufacturer is specified for the reagents and instruments used, all are conventional products that can be purchased through regular channels.

[0022] Example 1 This embodiment provides a single reagent for detecting α-L-fucosidase, which contains the following components: CNPF (Shanghai Xibao Biotechnology Co., Ltd.) with a concentration of 0.5 g / L, glycine-sodium hydroxide buffer (pH 5.0) with a concentration of 100 mmol / L, EDTA with a concentration of 2 mmol / L, magnesium sulfate with a concentration of 50 mmol / L, glycerol with a concentration of 10 g / L, Gemini surfactant octadecylamine polyoxyethylene ether diquaternary ammonium salt with a concentration of 0.5 g / L, TWEEN-80 with a concentration of 2.5 g / L, PEG-6000 with a concentration of 1.5 g / L, and sodium azide with a concentration of 2.5 g / L, and the solvent is water; The preparation method is as follows: weigh the buffer solid component, metal ion chelator, and inorganic compound containing metal ions according to the above concentration, dissolve them in water, adjust the pH to 5.0 after mixing, then add water to make the volume to the above concentration, and then add α-L-fucosidase activity determination substrate, protective agent, surfactant PEG and preservative to prepare the reagent or kit.

[0023] Example 2 This example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those of Example 1 only in that the Gemini surfactant is replaced with hexadecanol polyoxyethylene ether dimethyl octyl ammonium chloride of the same concentration.

[0024] Example 3 This example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those of Example 1 only in that the Gemini surfactant is replaced with octyl polyoxyethylene hexadecyl ammonium chloride of the same concentration.

[0025] Example 4 This example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those in Example 1 only in that TWEEN-80 is replaced by TWEEN-20 of the same concentration.

[0026] Example 5 This example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those of Example 1 only in that the buffer is replaced with a sodium dihydrogen phosphate-sodium dihydrogen phosphate buffer with the same concentration and pH value.

[0027] Example 6 This example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those of Example 1 only in that the buffer is replaced with a citric acid-sodium hydroxide buffer of the same concentration and pH value.

[0028] Example 7 This example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those of Example 1 only in that the buffer is replaced with an acetic acid-sodium acetate buffer with the same concentration and pH value.

[0029] Example 8 This example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those in Example 1 only in that magnesium sulfate is replaced by sodium chloride of the same concentration.

[0030] Example 9 This example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those in Example 1 only in that PEG is PEG-2000.

[0031] Example 10 This example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those in Example 1 only in that sodium azide is replaced by kanamycin of the same concentration.

[0032] Comparative Example 1 This comparative example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those in Example 1 only in that glycerol is replaced by mannitol of the same concentration.

[0033] Comparative Example 2 This comparative example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those in Example 1 only in that glycerol is replaced by sorbitol of the same concentration.

[0034] Comparative Example 3 This comparative example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those in Example 1 only in that glycerol is replaced by trehalose of the same concentration.

[0035] Comparative Example 4 This comparative example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those of Example 1 only in that the Gemini surfactant is replaced with a quaternary ammonium salt of alkylphenol polyoxyethylene ether of the same concentration.

[0036] Comparative Example 5 This comparative example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those of Example 1 only in that the Gemini surfactant is replaced with TRITON X-100 of the same concentration.

[0037] Comparative Example 6 This comparative example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those of Example 1 only in that TWEEN-80 is replaced by Span-80 of the same concentration.

[0038] Comparative Example 7 This comparative example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those of Example 1 only in that TWEEN-80 is replaced by TRITON X-100 of the same concentration.

[0039] Comparative Example 8 This comparative example provides a single reagent for detecting α-L-fucosidase, the components of which are different from those of Example 1 only in that no PEG component is added.

[0040] Test Example 1 This test example tests the stability of the α-L-fucosidase detection single reagents prepared in the above embodiments and comparative examples 1 to 7, and uses an accelerated stability test for testing. The specific steps are as follows: the above α-L-fucosidase detection single reagents are placed in a 37°C environment, and the same test sample is measured using a fully automatic biochemical analyzer (Hitachi 7180) on days 0, 1, 3, 5, 7, and 14, respectively. The detection parameters are as follows: main wavelength 405nm, temperature 37°C, cuvette light diameter 1cm, reaction direction is ascending reaction, reaction time 10min, and analysis type is Rate A. 20 microliters of physiological saline are added to the blank tube, 20 microliters of calibration products are added to the calibration tube, and 20 microliters of test samples are added to the sample tube, and they are mixed with 180 microliters of different single reagents, respectively, and kept at 37°C for 10 minutes, and the absorbance is read respectively; the blank tube is zeroed, the AFU concentration in the sample is calculated, the test is repeated 3 times and the data is averaged, and then the relative deviation (%) of the test sample and the average value of the test on day 0 is calculated. The experimental results are shown in Table 1.

[0041] Table 1

[0042] The results show that the combination of Gemini surfactant and Tween surfactant with protective agent glycerol can effectively slow down the acidolysis of substrate, thereby improving substrate stability. The relative deviation of the single reagent prepared in the embodiment of the present invention in the 37°C accelerated stability test for 14 days is still very small, which can prove that the single reagent of the present invention can be stably stored at 2-8°C for 20 months.

[0043] Test Example 2 In this test example, the anti-interference performance of the single reagent for α-L-fucosidase detection prepared in the above-mentioned embodiment and comparative example 8 is evaluated. The specific steps are as follows: different concentrations of interfering substances are added to the serum, and the above-mentioned single reagent is used to respectively measure the samples without added interfering substances and the samples after adding different concentrations of interfering substances on a fully automatic biochemical analyzer (the brand and model are the same as those in test example 1), and the test is repeated 3 times to take the average value of the data, and the deviation (%) of the test value of the sample after adding different concentrations of interfering substances and the test value of the sample without adding interfering substances is calculated. The experimental results are shown in Table 2.

[0044] Table 2

[0045] The results show that the single reagent of the present invention can resist the influence of multiple interferences including chylomicron, effectively remove the interference of bound bilirubin ≤40mg / dl, free bilirubin ≤40mg / dl, vitamin C ≤20mg / dl, chylomicron ≤250mg / dl and hemoglobin ≤400mg / dl, and has high sensitivity. In addition to the above tests, the present invention also uses multiple samples from other different sources for detection, and all achieve consistent technical effects.

[0046] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. An α-L-fucosidase detection reagent or kit, characterized in that: include: The α-L-fucosidase activity assay comprises a substrate, a buffer solution with a pH value of 4.5 to 5.5, a metal ion chelating agent, an inorganic compound containing metal ions, a protective agent, a surfactant and PEG; the protective agent is glycerol, and the surfactant is a Gemini surfactant and Tween.

2. The reagent or kit according to claim 1, characterized in that The buffer is any one of glycine-sodium hydroxide buffer, disodium hydrogen phosphate-sodium dihydrogen phosphate buffer, dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer, disodium hydrogen phosphate-citric acid buffer, citric acid-sodium citrate buffer, citric acid-sodium hydroxide buffer, MES-sodium hydroxide buffer, acetic acid-sodium acetate buffer, and potassium hydrogen phthalate-sodium hydroxide buffer.

3. The reagent or kit according to claim 1, characterized in that The metal ion chelating agent is at least one of EDTA, EDTA-2Na, EDTA-4Na and NTA.

4. The reagent or kit according to claim 1, characterized in that The inorganic compound containing metal ions is at least one of potassium chloride, sodium chloride, calcium chloride, magnesium sulfate and sodium sulfate.

5. The reagent or kit according to claim 1, characterized in that The Gemini surfactant is at least one of octyl polyoxyethylene hexadecyl ammonium chloride, octyl polyoxyethylene octadecyl ammonium chloride, dodecanol polyoxyethylene ether dimethyl methyl ammonium chloride, hexadecanol polyoxyethylene ether dimethyl octyl ammonium chloride, ethylene didodecyl polyoxyethylene polyoxypropylene block ammonium bromide, octadecylamine polyoxyethylene ether diquaternary ammonium salt, and hexadecanol polyoxyethylene ether dimethyl octyl ammonium chloride; the Tween is Tween-20 or Tween-80.

6. The reagent or kit according to claim 1, characterized in that The molecular weight of the PEG is 1000-20000.

7. The reagent or kit according to claim 1, characterized in that The reagent or kit may also include a preservative.

8. The reagent or kit according to claim 7, characterized in that The preservative is at least one of sodium azide, antibiotics, Proclin 300, and Krovin 100; and / or the concentration of the preservative is 0.5-5 g / L.

9. The reagent or kit according to claim 1, characterized in that The concentration of the substrate for the α-L-fucosidase activity assay is 0.2-2 g / L, the concentration of the buffer is 20-200 mmol / L, the concentration of the metal ion chelator is 0.5-5 mmol / L, the concentration of the inorganic compound containing metal ions is 10-100 mmol / L, the concentration of the protective agent is 2-20 g / L, the concentration of the surfactant is 1-10 g / L, and the concentration of PEG is 0.5-10 g / L.

10. The method for preparing the reagent or kit according to any one of claims 1 to 9, characterized in that: include: The buffer solution, the metal ion chelating agent and the inorganic compound containing the metal ions are mixed and the pH value is adjusted to 4.5-5.5, and then the mixture is mixed with the substrate for determining the activity of α-L-fucosidase, the protective agent, the surfactant and PEG to prepare the reagent or the kit.

Citation Information

Patent Citations

  • Liquid single reagent for detecting alpha-L-fucosidase and preparation method thereof

    CN102967571A

  • Serum AFU detection kit

    CN104267178A

  • Alpha-L-fucosidase detection kit and preparation method thereof

    CN105238848A

  • Surfactant composition applied to in vitro diagnostic reagent

    CN109596834A

  • Kit for detecting apolipoprotein A1 and application thereof

    CN115078739A